Via Oncology Overview
- Founded
-
2009

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Via Oncology General Information
Description
Developer of a healthcare software to support oncology healthcare practices. The company's healthcare software offers evidence-based, point-of-care decision-making tools, including a platform for disease committees and forum, clinical content, oncology decision support, reports of key metrics and communications materials, messages and strategies, enabling patients to get assistance through the development and implementation of clinical pathways in collaboration with its network of cancer centers.
Contact Information
Website
www.viaoncology.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Outcome Management (Healthcare)
Other Industries
Diagnostic Equipment
Drug Discovery
Acquirer
Primary Office
- 1251 Waterfront Place
- 5th Floor
- Pittsburgh, PA 15222
- United States
Via Oncology Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Via Oncology Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a healthcare software to support oncology healthcare practices. The company's healthcare software offers ev
Outcome Management (Healthcare)
Pittsburgh, PA
000000&0
Via Oncology Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
OncoHealth (Atlanta) | Private Equity-Backed | Atlanta, GA | 000 | 000.00 | 0000000 0000 | |
000000 | Venture Capital-Backed | New York, NY | 000 | 00000 | 00000000000 | 00000 |
000000 | Venture Capital-Backed | Irving, TX | 00 | 000.00 | 00000000000 | 000.00 |
0000000 | Venture Capital-Backed | Edinburgh, United Kingdom | 00 | 00.000 | 0000000000 0 | 00.000 |
Via Oncology Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|